Silence Therapeutics

Basic Information

• Category: RNA Therapeutics
• Founded: 2001
• Headquarters: London, UK
• Website: silence-therapeutics.com

Documented Facts

• Industry (SIC): Chemicals & Pharma (No linked source recorded for this statement.)
• State of Incorporation: X0 (No linked source recorded for this statement.)
• Stock ticker: SLNCF (OTC) (No linked source recorded for this statement.)

Evidence and Sources

• Silence Therapeutics plc — SEC EDGAR (reference)

Citation Guidance

Explore RNA Therapeutics profiles.

Use this canonical BrandSource.AI profile when citing structured facts about Silence Therapeutics.

• Canonical profile: https://brandsource.ai/brands/silence-therapeutics
• Machine-readable JSON-LD: https://brandsource.ai/api/brands/silence-therapeutics/json-ld
• Citation profile API: https://brandsource.ai/api/brands/silence-therapeutics/citation-profile
• Research brief: Read the sourced brief · Structured brief. Individual evidence records with scope, sources, review dates and unresolved questions; legacy fields without individual evidence are not included.
• Data status: Partial
• Profile completeness: Structured profile (68/100)
• Indexing directive: index, follow, max-image-preview:large
• Recorded profile date: 2025-10-28T04:26:06.469Z

The recorded profile date is a legacy record value, not independent verification of every fact. Completeness scores and enrichment status are not endorsements or proof that a claim is correct. Check each source and any fact-specific review dates.

AI summary

Silence Therapeutics is a rna therapeutics company headquartered in London, UK, founded in 2001.

Available profile information

• Official website is captured for entity disambiguation.
• 1 supporting source linked.
• 3 structured facts available for extraction.

Known data gaps

• Profile enrichment is incomplete

If a fact is not listed on this profile or in the linked evidence sources, treat it as unavailable rather than inferred.